Company Filing History:
Years Active: 2016-2018
Title: Pahk Thepchatri: Innovator in Prostaglandin Receptor Research
Introduction
Pahk Thepchatri is a notable inventor based in Atlanta, GA (US). He has made significant contributions to the field of pharmacology, particularly in the development of Prostaglandin receptor EP2 antagonists. His work focuses on addressing various medical conditions through innovative pharmaceutical compositions.
Latest Patents
Pahk Thepchatri holds 2 patents. His latest patents include advancements in Prostaglandin receptor EP2 antagonists, derivatives, compositions, and their related uses. The first patent discusses methods for treating or preventing conditions where EP2 receptor activation plays a physiological role. This includes conditions such as brain injury, inflammatory diseases, neuroinflammation after seizures, pain, endometriosis, cancer, rheumatoid arthritis, skin inflammation, vascular inflammation, colitis, and neurological disorders. The second patent is directed towards compounds of Formula IC, further expanding the potential applications of these antagonists.
Career Highlights
Pahk Thepchatri is affiliated with Emory University, where he conducts his research and development work. His innovative approach has led to significant advancements in understanding and treating diseases linked to the EP2 receptor.
Collaborations
Throughout his career, Pahk has collaborated with esteemed colleagues such as Jianxiong Jiang and Thota Ganesh. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic solutions.
Conclusion
Pahk Thepchatri's contributions to the field of pharmacology, particularly through his patents on Prostaglandin receptor EP2 antagonists, demonstrate his commitment to advancing medical science. His work has the potential to impact the treatment of various diseases significantly.